Cover Image
Market Research Report
Product code 
1087864

Latin America In Vitro Diagnostics Market by Product & Service, Technology (Immunoassay, Point of Care, Molecular Diagnostics), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), Customer Type - Forecast to 2029

Published: | Meticulous Market Research Pvt. Ltd. | 191 Pages | Delivery time: 1-2 business days

Price

Back to Top
Latin America In Vitro Diagnostics Market by Product & Service, Technology (Immunoassay, Point of Care, Molecular Diagnostics), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), Customer Type - Forecast to 2029
Published: June 8, 2022
Meticulous Market Research Pvt. Ltd.
Content info: 191 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Latin America in vitro diagnostics (IVD) market is expected to grow at a CAGR of 7.8% during the forecast period 2022-2029 to reach $7.75 billion by 2029.

The report provides the key industry drivers, restraints, challenges, and opportunities through extensive secondary and primary research and in-depth analysis of the market scenario. The growth in the Latin America IVD market is attributed to the increasing prevalence of diseases, rising geriatric population, growing awareness for early disease diagnosis, a shift in the focus from centralized to the point of care testing, and the emergence of the COVID-19 pandemic. Moreover, the inclination towards personalized healthcare and advancements in genomics and proteomics offer significant growth opportunities for the players operating in this market.

Based on product & service, in 2022, the kits & reagents segment is estimated to account for the largest share of the Latin America IVD market. This segment is also expected to grow at the fastest CAGR during the forecast period. The reagents used in diagnostic testing assays are critical for the proper functioning of any diagnostic facility providing IVD testing. Increasing virulence of infectious diseases and rapid growth in molecular testing for hospital-acquired infections has led to the development of PoC tests & kits. The advent of PoC testing has increased the demand for kits & reagents.

Based on application, the oncology segment is expected to grow at the fastest CAGR during the forecast period. The in vitro diagnostic for oncology consists of tests or medical devices that examine specimens taken from the human body and provide essential data for screening, diagnosis, and treatment of cancer. Advancements in technology and immunochemistry have led to point of care (PoC) testing and self-testing for cancer diagnosis. Furthermore, the increasing prevalence of cancer in Latin America is expected to drive the growth of in vitro diagnostics for oncology applications.

Based on diagnostic approach, the point of care testing is estimated to account for the largest share of the Latin America IVD market. Latin American counties have a lower health-system capacity and weaker disease surveillance systems than some developed countries; hence point of care testing becomes an important tool to increase the population's diagnostic coverage.

Based on customer type, the home care/self-testing segment is expected to grow at the fastest CAGR during the forecast period. Factors such as the outbreak of the COVID-19 pandemic, increasing need to manage and monitor chronic diseases, rising awareness for the use of home healthcare testing products, and the need to reduce waiting time for testing results & healthcare costs are leading to the growth of the segment. However, home care IVD products possess some potential challenges, such as device failure, inaccurate test results, the user's inability to interpret test results, and failure to take necessary follow-up measures, which may restrain the growth of this segment to some extent.

An in-depth analysis of the geographical scenario of the Latin America IVD market provides detailed qualitative and quantitative insights about the major countries - Brazil, Mexico, Colombia, Chile, Argentina, Peru, Uruguay, Ecuador, the Dominican Republic, Paraguay, Bolivia, and the Rest of Latin America. In 2022, Brazil is estimated to account for the largest share of the Latin America IVD market, followed by Mexico, Argentina, Colombia, and Chile.

The key players operating in the Latin America in vitro diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), bioMerieux SA (France), Qiagen N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Wama Diagnostica (Brazil), and Wiener Laboratorios SAIC (Argentina).

Scope of the Report:

Latin America In Vitro Diagnostics Market, by Product & Service

  • Kits & Reagents
  • Instruments
  • Software & Services

Latin America In Vitro Diagnostics Market, by Technology

  • Immunoassay
  • Whole Blood Glucose Monitoring
  • Molecular Diagnostics
  • Point of Care Diagnostics
  • Clinical Chemistry
  • Hematology
  • Coagulation & Hemostasis
  • Critical Care Diagnostics
  • Urinalysis
  • Other Technologies

Other technologies comprise microscopy, hybridization, and loop-mediated amplification

Latin America In Vitro Diagnostics Market, by Application

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Endocrinology
  • Cardiology
  • Other Applications

Other applications comprise nephrology, toxicology, gastroenterology, neonatal, genetic, and neurological disorders.

Latin America In Vitro Diagnostics Market, by Diagnostic Approach

  • Lab Testing
  • OTC/Self-testing
  • Point of Care Testing

Latin America In Vitro Diagnostics Market, by Customer Type

  • Hospital Laboratories
  • Private Laboratories
  • Home Care/Self-testing
  • Government Bodies
  • Other Customers

Other customers comprise long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories.

Latin America In Vitro Diagnostics Market, by Country/Region

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Ecuador
  • Uruguay
  • Dominican Republic
  • Paraguay
  • Bolivia
  • Rest of Latin America
Product Code: MRHC - 104407

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-up Approach
      • 2.3.1.2. Top-down Approach
      • 2.3.1.3. Growth forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Rising Prevalence of Communicable and Non-communicable Diseases
    • 4.2.2. Growing Awareness Regarding Early Disease Diagnosis
    • 4.2.3. Adoption of Point of Care Testing
    • 4.2.4. Expanding Medical Tourism in the Region
  • 4.3. Opportunities
    • 4.3.1. Inclination towards Personalized Healthcare or Personalized Medicine
    • 4.3.2. Advances in Genomics and Proteomics
  • 4.4. Challenges
    • 4.4.1. Regulatory Scenario in Latin American Countries
  • 4.5. COVID-19 Impact on Latin America In Vitro Diagnostics Market

5. Latin America In Vitro Diagnostics Market, by Product & Service

  • 5.1. Introduction
  • 5.2. Kits & Reagents
  • 5.3. Instruments
  • 5.4. Software & Services

6. Latin America In Vitro Diagnostics Market, by Technology

  • 6.1. Introduction
  • 6.2. Immunoassay
  • 6.3. Whole Blood Glucose Monitoring
  • 6.4. Molecular Diagnostics
  • 6.5. Point of Care Diagnostics
  • 6.6. Clinical Chemistry
  • 6.7. Haematology
  • 6.8. Coagulation & Haemostasis
  • 6.9. Critical Care Diagnostics
  • 6.10. Urinalysis
  • 6.11. Other Technologies

7. Latin America In Vitro Diagnostics Market, by Application

  • 7.1. Introduction
  • 7.2. Infectious Diseases
  • 7.3. Diabetes
  • 7.4. Oncology
  • 7.5. Endocrinology
  • 7.6. Cardiology
  • 7.7. Other Applications

8. Latin America In Vitro Diagnostics Market, by Diagnostic Approach

  • 8.1. Introduction
  • 8.2. Lab Testing
  • 8.3. OTC/Self-testing
  • 8.4. Point of Care Testing

9. Latin America In Vitro Diagnostics Market, by Customer Type

  • 9.1. Introduction
  • 9.2. Hospital Laboratories
  • 9.3. Private Laboratories
  • 9.4. Home Care/Self-testing
  • 9.5. Government Bodies
  • 9.6. Other Customer Types

10. Latin America In Vitro Diagnostics Market, by Country/Region

  • 10.1. Introduction
  • 10.2. Brazil
  • 10.3. Mexico
  • 10.4. Argentina
  • 10.5. Colombia
  • 10.6. Peru
  • 10.7. Chile
  • 10.8. Ecuador
  • 10.9. Uruguay
  • 10.10. Dominican Republic
  • 10.11. Paraguay
  • 10.12. Bolivia
  • 10.13. Rest of Latin America

11. Competitive landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Market Share Analysis (2021)

12. Company Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Becton, Dickinson and Company
  • 12.3. bioMerieux SA
  • 12.4. Danaher Corporation
  • 12.5. F. Hoffman-la Roche Ltd.
  • 12.6. Qiagen N.V.
  • 12.7. Siemens Healthineers AG
  • 12.8. Thermo Fisher Scientific Inc.
  • 12.9. Wama Diagnostica
  • 12.10. Wiener Laboratorios SAIC

13. Appendix

  • 13.1. Questionnaire

List of Tables

  • Table 1 Latin America In Vitro Diagnostics Market Drivers: Impact Analysis (2022-2029)
  • Table 2 Latin America: Number of New HIV Cases by Country (2019 VS 2020)
  • Table 3 Latin America: Medical Tourism Destinations
  • Table 4 Latin America: Medical Tourism Index and Rankings (2020-2021)
  • Table 5 Personalized Health Index: Latin America
  • Table 6 Coronavirus Cases, Deaths, and Related Tests in Latin America (Till May 2022)
  • Table 7 Health Measures Implemented in Response to the COVID-19 Crisis in Latin America (2020)
  • Table 8 Latin America In Vitro Diagnostics Market Size, by Product & Service, 2020-2029 (USD Million)
  • Table 9 Latin America In Vitro Diagnostics Kits & Reagents Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 10 Latin America In Vitro Diagnostics Instruments Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 11 Latin America In Vitro Diagnostics Instruments Market Volume, by Country/Region, 2020-2029 (Hundred Units)
  • Table 12 Price of In Vitro Diagnostics Instruments in Latin America, 2021
  • Table 13 Latin America In Vitro Diagnostics Software & Services Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 14 Latin America In Vitro Diagnostics Market, by Technology, 2020-2029

(USD Million)

  • Table 15 Latin America Immunoassay Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 16 Latin America Whole Blood Glucose Monitoring Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 17 Latin America Molecular Diagnostics Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 18 Latin America Point of Care Diagnostics Market Size, by Country/Region,2020-2029 (USD Million)
  • Table 19 Latin America Clinical Chemistry Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 20 Latin America Haematology Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 21 Latin America Coagulation and Haemostasis Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 22 Critical Care Diagnostics Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 23 Latin America Urinalysis Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 24 Latin America other In Vitro Diagnostics Technologies Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 25 Latin America In Vitro Diagnostics Market Size, by Application, 2020-2029 (USD Million)
  • Table 26 Covid-19 Cases & Mortalities in Latin America (As of May 2022)
  • Table 27 Latin America: Number of HIV Cases (Adults & Children), by Country '2019' and '2020'
  • Table 28 Technologies and their Applications in Various Infectious Diseases
  • Table 29 Latin America In Vitro Diagnostics Market Size for infectious Diseases, by Country/Region, 2022-2029 (USD Million)
  • Table 30 Latin America: Diabetes Cases, by Country (2021 VS 2030)
  • Table 31 Latin America In Vitro Diagnostics Market Size for Diabetes, by Country/Region, 2022-2029 (USD Million)
  • Table 32 Latin America: Cancer Cases, by Country (2020 VS 2030)
  • Table 33 Latin America In Vitro Diagnostics Market Size for Oncology, by Country/Region, 2022-2029 (USD Million)
  • Table 34 Latin America In Vitro Diagnostics Market Size for Endocrinology, by Country/Region, 2022-2029 (USD Million)
  • Table 35 Latin America: Deaths due to Cardiovascular Diseases, by Country (2019)
  • Table 36 Latin America In Vitro Diagnostics Market Size for Cardiology, by Country/Region, 2022-2029 (USD Million)
  • Table 37 Latin America In Vitro Diagnostics Market Size for Other Applications, by Country/Region, 2022-2029 (USD Million)
  • Table 38 Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020-2029 (USD Million)
  • Table 39 Latin America In Vitro Diagnostics Market Size for Lab Testing, by Country/Region, 2022-2029 (USD Million)
  • Table 40 Latin America In Vitro Diagnostics Market Size for OTC/Self-testing, by Country/Region, 2022-2029 (USD Million)
  • Table 41 Latin America In Vitro Diagnostics Market Size for Point of Care Testing, by Country/Region, 2022-2029 (USD Million)
  • Table 42 Latin America In Vitro Diagnostics Market Size, by Customer Type, 2020-2029 (USD Million)
  • Table 43 Top Ranking Hospitals in Latin America
  • Table 44 Latin America In Vitro Diagnostics Market Size for Hospital Laboratories, by Country/Region, 2022-2029 (USD Million)
  • Table 45 Latin America In Vitro Diagnostics Market Size for Private Laboratories, by Country/Region, 2022-2029 (USD Million)
  • Table 46 Latin America In Vitro Diagnostics Market Size for Home Care/Self-testing, by Country/Region, 2022-2029 (USD Million)
  • Table 47 Latin America: Healthcare Expenditure, by Country/Region (2019)
  • Table 48 Latin America In Vitro Diagnostics Market Size for Government Bodies, by Country/Region, 2022-2029 (USD Million)
  • Table 49 Latin America In Vitro Diagnostics Market Size for Other Customer Types, by Country/Region, 2022-2029 (USD Million)
  • Table 50 Latin America in Vitro Diagnostic Market, by Country/Region, 2020-2029 (USD Million)
  • Table 51 Latin America: Latin America In Vitro Diagnostics Market Size, by Product & Service, (2020-2029) (USD Million)
  • Table 52 Latin America: Latin America In Vitro Diagnostics Market Size, by Technology, (2020-2029) (USD Million)
  • Table 53 Latin America: Latin America In Vitro Diagnostics Market Size, by Application, (2020-2029) (USD Million)
  • Table 54 Latin America: Latin America In Vitro Diagnostics Market Size, by Customer Type, (2020-2029) (USD Million)
  • Table 55 Latin America: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020-2029) (USD Million)
  • Table 56 Testing Initiatives for COVID-19 in Brazil
  • Table 57 Brazil: Macroindicators
  • Table 58 Brazil: Latin America In Vitro Diagnostics Market Size, by Product & Service, (2020-2029) (USD Million)
  • Table 59 Brazil: Latin America In Vitro Diagnostics Market Size, by Technology, (2020-2029) (USD Million)
  • Table 60 Brazil: Latin America In Vitro Diagnostics Market Size, by Application, (2020-2029) (USD Million)
  • Table 61 Brazil: Latin America In Vitro Diagnostics Market Size, by Customer Type, (2020-2029) (USD Million)
  • Table 62 Brazil: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020-2029) (USD Million)
  • Table 63 Mexico: Some of the Serological Tests Approved by the National Institute and Reference "Dr. Manuel Martinez Baez" (Indre) against COVID-19
  • Table 64 Mexico: Macroindicators
  • Table 65 Mexico: Latin America In Vitro Diagnostics Market Size, by Product & Service, (2020-2029) (USD Million)
  • Table 66 Mexico: Latin America In Vitro Diagnostics Market Size, by Technology, (2020-2029) (USD Million)
  • Table 67 Mexico: Latin America In Vitro Diagnostics Market Size, by Application, (2020-2029) (USD Million)
  • Table 68 Mexico: Latin America In Vitro Diagnostics Market Size, by Customer Type, (2020-2029) (USD Million)
  • Table 69 Mexico: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020-2029) (USD Million)
  • Table 70 Argentina: Macroindicators
  • Table 71 Argentina: Latin America In Vitro Diagnostics Market Size, by Product & Service, (2020-2029) (USD Million)
  • Table 72 Argentina: Latin America In Vitro Diagnostics Market Size, by Technology, (2020-2029) (USD Million)
  • Table 73 Argentina: Latin America In Vitro Diagnostics Market Size, by Application, (2020-2029) (USD Million)
  • Table 74 Argentina: Latin America In Vitro Diagnostics Market Size, by Customer Type, (2020-2029) (USD Million)
  • Table 75 Argentina: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020-2029) (USD Million)
  • Table 76 Colombia: Macroindicators
  • Table 77 Colombia: Latin America In Vitro Diagnostics Market Size, by Product & Service, (2020-2029) (USD Million)
  • Table 78 Colombia: Latin America In Vitro Diagnostics Market Size, by Technology, (2020-2029) (USD Million)
  • Table 79 Colombia: Latin America In Vitro Diagnostics Market Size, by Application, (2020-2029) (USD Million)
  • Table 80 Colombia: Latin America In Vitro Diagnostics Market Size, by Customer Type, (2020-2029) (USD Million)
  • Table 81 Colombia: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020-2029) (USD Million)
  • Table 82 Peru: Macroindicators
  • Table 83 Peru: Latin America In Vitro Diagnostics Market Size, by Product & Service, (2020-2029) (USD Million)
  • Table 84 Peru: Latin America In Vitro Diagnostics Market Size, by Technology, (2020-2029) (USD Million)
  • Table 85 Peru: Latin America In Vitro Diagnostics Market Size, by Application, (2020-2029) (USD Million)
  • Table 86 Peru: Latin America In Vitro Diagnostics Market Size, by Customer Type, (2020-2029) (USD Million)
  • Table 87 Peru: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020-2029) (USD Million)
  • Table 88 Chile: Macroindicators
  • Table 89 Chile: Latin America In Vitro Diagnostics Market Size, by Product & Service, (2020-2029) (USD Million)
  • Table 90 Chile: Latin America In Vitro Diagnostics Market Size, by Technology, (2020-2029) (USD Million)
  • Table 91 Chile: Latin America In Vitro Diagnostics Market Size, by Application, (2020-2029) (USD Million)
  • Table 92 Chile: Latin America In Vitro Diagnostics Market Size, by Customer Type, (2020-2029) (USD Million)
  • Table 93 Chile: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020-2029) (USD Million)
  • Table 94 Ecuador: Macroindicators
  • Table 95 Ecuador: Latin America In Vitro Diagnostics Market Size, by Product & Service, 2020-2029 (USD Million)
  • Table 96 Ecuador: Latin America In Vitro Diagnostics Market Size, by Technology, 2020-2029 (USD Million)
  • Table 97 Ecuador: Latin America In Vitro Diagnostics Market Size, by Application, 2020-2029 (USD Million)
  • Table 98 Ecuador: Latin America In Vitro Diagnostics Market Size, by Customer Type, 2020-2029 (USD Million)
  • Table 99 Ecuador: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020-2029 (USD Million)
  • Table 100 Uruguay: Macroindicators
  • Table 101 Uruguay: Latin America In Vitro Diagnostics Market Size, by Product & Service, 2020-2029 (USD Million)
  • Table 102 Uruguay: Latin America In Vitro Diagnostics Market Size, by Technology, 2020-2029 (USD Million)
  • Table 103 Uruguay: Latin America In Vitro Diagnostics Market Size, by Application, 2020-2029 (USD Million)
  • Table 104 Uruguay: Latin America In Vitro Diagnostics Market Size, by Customer Type, 2020-2029 (USD Million)
  • Table 105 Uruguay: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020-2029 (USD Million)
  • Table 106 Dominican Republic: Macroindicators
  • Table 107 Dominican Republic: Latin America In Vitro Diagnostics Market Size, by Product & Service, 2020-2029 (USD Million)
  • Table 108 Dominican Republic: Latin America In Vitro Diagnostics Market Size, by Technology, 2020-2029 (USD Million)
  • Table 109 Dominican Republic: Latin America In Vitro Diagnostics Market Size, by Application, 2020-2029 (USD Million)
  • Table 110 Dominican Republic: Latin America In Vitro Diagnostics Market Size, by CustomerType,2020-2029 (USD Million)
  • Table 111 Dominican Republic: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020-2029 (USD Million)
  • Table 112 Paraguay: Macroindicators
  • Table 113 Paraguay: Latin America In Vitro Diagnostics Market Size, by Product & Service, 2020-2029 (USD Million)
  • Table 114 Paraguay: Latin America In Vitro Diagnostics Market Size, by Technology, 2020-2029 (USD Million)
  • Table 115 Paraguay: Latin America In Vitro Diagnostics Market Size, by Application, 2020-2029 (USD Million)
  • Table 116 Paraguay: Latin America In Vitro Diagnostics Market Size, by Customer Type, 2020-2029 (USD Million)
  • Table 117 Paraguay: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020-2029 (USD Million)
  • Table 118 Bolivia: Top 5 Causes of Deaths (2020)
  • Table 119 Bolivia: Macroindicators
  • Table 120 Bolivia: Latin America In Vitro Diagnostics Market Size, by Product & Service, 2020-2029 (USD Million)
  • Table 121 Bolivia: Latin America In Vitro Diagnostics Market Size, by Technology, 2020-2029 (USD Million)
  • Table 122 Bolivia: Latin America In Vitro Diagnostics Market Size, by Application, 2020-2029 (USD Million)
  • Table 123 Bolivia: Latin America In Vitro Diagnostics Market Size, by Customer Type, 2020-2029 (USD Million)
  • Table 124 Bolivia: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020-2029 (USD Million)
  • Table 125 Rest of Latin America: Macroindicators
  • Table 126 Rest of Latin America: Latin America In Vitro Diagnostics Market Size, by Product & Service, 2020-2029 (USD Million)
  • Table 127 Rest of Latin America: Latin America In Vitro Diagnostics Market Size, by Technology, 2020-2029 (USD Million)
  • Table 128 Rest of Latin America: Latin America In Vitro Diagnostics Market Size, by Application, 2020-2029 (USD Million)
  • Table 129 Rest of Latin America: Latin America In Vitro Diagnostics Market Size, by Customer Type, 2020-2029 (USD Million)
  • Table 130 Rest of Latin America: Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020-2029 (USD Million)
  • Table 131 Recent Developments, by Company, 2019-2022
  • Table 132 Abbott Laboratories in Latin America
  • Table 133 Becton, Dickinson and Company (BD): Subsidiaries in Latin America
  • Table 134 F. Hoffmann-La Roche Ltd: Subsidiaries and Associates in Latin America

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Latin America In Vitro Diagnostics Market Size, by Product & Service, 2022 VS 2029 (USD Million)
  • Figure 8 Latin America In Vitro Diagnostics Market Size, by Technology, 2022 VS 2029 (USD Million)
  • Figure 9 Latin America In Vitro Diagnostics Market Size, by Application, 2022 VS 2029 (USD Million)
  • Figure 10 Latin America In Vitro Diagnostics Market Size, by Customer Type, 2022 VS 2029 (USD Million)
  • Figure 11 Latin America In Vitro Diagnostics Market Size, by Country/Region
  • Figure 12 Market Dynamics
  • Figure 13 Latin America In Vitro Diagnostics Market Size, by Product & Service, 2022-2029 (USD Million)
  • Figure 14 Latin America In Vitro Diagnostics Market, by Technology, 2022 VS 2029 (USD Million)
  • Figure 15 Adult Population (20-79 Years) with Diabetes in Latin American Countries (Millions) (2021)
  • Figure 16 Latin America In Vitro Diagnostics Market Size, by Application, 2022-2029 (USD Million)
  • Figure 17 Diabetes Prevalence in the South and Central America Region
  • Figure 18 Latin America: Estimated Number of New Cancer Cases (2020-2040)
  • Figure 19 Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2022-2029 (USD Million)
  • Figure 20 Benefits of Lab Testing Approach
  • Figure 21 Benefits of Point of Care Testing Approach
  • Figure 22 Latin America In Vitro Diagnostics Market Size, by Customer Type, 2022-2029 (USD Million)
  • Figure 23 Latin America In Vitro Diagnostics Market: Snapshot
  • Figure 24 Brazil: Challenges to the In Vitro Diagnostics Market
  • Figure 25 Key Growth Strategies Adopted by Leading Players, 2019-2022
  • Figure 26 Latin America In Vitro Diagnostics Market: Competitive Benchmarking
  • Figure 27 Market Share Analysis: Latin America In Vitro Diagnostics Industry, 2021
  • Figure 28 Abbott Laboratories: Financial Overview, (2021)
  • Figure 29 Becton, Dickinson and Company: Financial Overview, (2021)
  • Figure 30 bioMerieux SA: Financial Overview, (2021)
  • Figure 31 Danaher Corporation: Financial Overview, (2021)
  • Figure 32 F. Hoffman-La Roche Ltd.: Financial Overview, (2021)
  • Figure 33 Qiagen N.V.: Financial Overview, (2021)
  • Figure 34 Siemens Healthineers AG: Financial Overview (2021)
  • Figure 35 Thermo Fisher Scientific Inc.: Financial Overview, (2021)